Riposte Capital’s Astera Labs ALAB Stock Holding History

Riposte Capital’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-60,000	Closed	-$6.58M	–	41
2026 Q1	$6.58M	Buy	+60,000	New	+$8.55M	1.68%	20

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Riposte Capital's ALAB Position: Q2 2026 in Review

Riposte Capital sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 60,000 shares — an estimated $6.58M sold.

Riposte Capital first reported a position in ALAB in Q1 2026 and held it in 1 quarter. The position peaked at $6.58M in Q1 2026. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Riposte Capital reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
Riposte Capital sold 60,000 Astera Labs shares in Q2 2026, an estimated $6.58M.
Riposte Capital first reported a position in Astera Labs in Q1 2026 and held it in 1 quarter.
Riposte Capital's Astera Labs position peaked at $6.58M in Q1 2026.
988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Riposte Capital's 13F filing for Q2 2026, filed 14 Aug 2026.